The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer
Official Title: A Phase 1 Study of TAS0612 in Patients With Locally Advanced or Metastatic Solid Tumors
Study ID: NCT04586270
Brief Summary: The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Tennessee Oncology, Nashville, Tennessee, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Centre de Lutte Contre le Cancer Gustave Roussy, Villejuif, Val De Marne, France